358
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference

, , , , , , , , , , , , , , , & show all
Pages 1612-1622 | Received 05 May 2010, Accepted 22 May 2010, Published online: 14 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Wojciech Jurczak, Alicja M. Gruszka, Anna Sowa Staszczak, Monika Dlugosz-Danecka, Marta Szostek, Dagmara Zimowska-Curylo, Agnieszka Giza, Katarzyna Krawczyk, Malgorzata Jakobczyk, Alicja Hubalewska-Dydejczyk, Michal Szymczyk, Tomasz Wróbel, Wanda Knopińska-Posłuszny, Elżbieta Kisiel, Aleksander Skotnicki & Pier Luigi Zinzani. (2019) Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up. Leukemia & Lymphoma 60:11, pages 2689-2696.
Read now
Francesco Zaja, Massimo Federico, Umberto Vitolo & Pier Luigi Zinzani. (2014) Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies. Leukemia & Lymphoma 55:5, pages 988-998.
Read now
Karem Humala & Anas Younes. (2013) Current and emerging new treatment strategies for mantle cell lymphoma. Leukemia & Lymphoma 54:5, pages 912-921.
Read now
Martin Dreyling, Hanneke C. Kluin-Nelemans, Sílvia Beà, Elena Hartmann, Itziar Salaverria, Grit Hutter, Patricia Perez-Galan, Gael Roue, Christiane Pott, Steven Le Gouill, Sergio Cortelazzo, Simon Rule, Georg Hess, Francesco Zaja, Umberto Vitolo, Michal Szymczyk, Jan Walewski, Vincent Ribrag, Michael Unterhalt, Olivier Hermine & Eva Hoster. (2011) Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network. Leukemia & Lymphoma 52:12, pages 2226-2236.
Read now

Articles from other publishers (16)

Ali Sakhdari, Chi Young Ok, Keyur P. Patel, Rashmi Kanagal-Shamanna, C. Cameron Yin, Zhuang Zuo, Shimin Hu, Mark J. Routbort, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Joseph D. Khoury & Sanam Loghavi. (2019) TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant. Annals of Diagnostic Pathology 41, pages 38-42.
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Ryan T. Phan. 2018. Atlas of Hematopathology. Atlas of Hematopathology 541 556 .
Niklas Vogt & Wolfram Klapper. (2012) Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression. Histopathology 62:2, pages 334-342.
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Wayne W. Grody. 2013. Atlas of Hematopathology. Atlas of Hematopathology 411 425 .
Pauline Brice & Catherine ThieblemontS. Le Gouill & A. Moreau. 2013. Actualités thérapeutiques dans les lymphomes. Actualités thérapeutiques dans les lymphomes 103 123 .
Richa Dawar & Francisco J. Hernandez-Ilizaliturri. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 81 98 .
P. McKay, M. Leach, R. Jackson, G. Cook & S. Rule. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology 159:4, pages 405-426.
Crossref
Pierre Peterlin, Christophe Leux, Thomas Gastinne, Virginie Roland, Béatrice Mahé, Viviane Dubruille, Jacques Delaunay, Patrice Chevallier, Thierry Guillaume, Nicolas Blin, Sameh Ayari, Aline Clavert, Mohamad Mohty, Christelle Dousset, Noel Milpied, Jean Luc Harousseau, Philippe Moreau, Soraya Wuilleme, Anne Moreau & Steven Le Gouill. (2012) Is ASCT With TBI Superior to ASCT Without TBI in Mantle Cell Lymphoma Patients?. Transplantation 94:3, pages 295-301.
Crossref
Estelle Gimenez, Martine Chauvet, Laetitia Rabin, Isabelle Puteaud, Samuel Duley, Sieme Hamaidia, Juliana Bruder, Valérie Rolland-Neyret, Steven Le Gouill, Olivier Tournilhac, Eric Voog, Hervé Maisonneuve, Marie C. Jacob, Dominique Leroux, Marie C. Béné, Christine Formisano-Tréziny, Jean Gabert, Rémy Gressin & Mary B. Callanan. (2012) Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang . British Journal of Haematology 158:2, pages 186-197.
Crossref
Jasmine Zain. (2012) Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma. Hematology/Oncology Clinics of North America 26:3, pages 671-704.
Crossref
Richa Dawar & Francisco Hernandez-Ilizaliturri. (2012) The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL). Best Practice & Research Clinical Haematology 25:2, pages 185-190.
Crossref
Yoonmi Seok, Juwon Kim, Jong Rak Choi, Yu Ri Kim, Seo-Jin Park, Sue Jung Kim, Jaewoo song & Kyung-A Lee. (2012) CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations. Annals of Laboratory Medicine 32:1, pages 95-98.
Crossref
Richard J. JonesVeerabhadran BaladandayuthapaniSattva NeelapuLuis E. FayadJorge E. RomagueraMichael WangRakesh SharmaDajun Yang & Robert Z. Orlowski. (2011) HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma. Blood 118:15, pages 4140-4149.
Crossref
Stéphanie Harel, Richard Delarue, Vincent Ribrag, Martin Dreyling & Olivier Hermine. (2011) Treatment of Younger Patients With Mantle Cell Lymphoma. Seminars in Hematology 48:3, pages 194-207.
Crossref
Erika Ramsdale, Koen van Besien & Sonali M. Smith. (2011) Personalized Treatment of Lymphoma: Promise and Reality. Seminars in Oncology 38:2, pages 225-235.
Crossref
V. Camara-Clayette, O. Hermine & V. Ribrag. (2011) Lymphome du manteau : un modèle biologique et clinique. EMC - Hématologie 6:2, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.